Free Trial
OTCMKTS:TSNDF

TerrAscend Q3 2026 Earnings Results & Report

TerrAscend logo
$0.45 0.00 (-0.81%)
As of 01:51 PM Eastern

TerrAscend missed analyst earnings expectations but beat on revenue in its Q3 2026 results, released November 5, 2026. The company reported EPS of -$0.02 versus the -$0.01 consensus estimate, while revenue of $68.21 million topped the $66.85 million estimate by $1.36 million.

Earnings Announcement Details

Quarter
Q3 2026
Report Date
Time
After Market Closes

TerrAscend EPS Results

Actual EPS
-$0.02
Consensus EPS
-$0.01
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A
EPS Beat Rate
1 of last 8 quarters

TerrAscend Revenue Results

Actual Revenue
$68.21 million
Expected Revenue
$66.85 million
Beat/Miss
Beat by +$1.36 million
YoY Revenue Growth
N/A

Conference Call Resources

TerrAscend Q3 2026 Earnings FAQ

TerrAscend (OTCMKTS:TSNDF) reported earnings of -$0.02 per share for Q3 2026, missing the consensus estimate of -$0.01. The report was announced on Thursday, November 5, 2026.

TerrAscend reported revenue of $68.21 million for Q3 2026, against a consensus estimate of $66.85 million.

TerrAscend Earnings Headlines

TerrAscend Reports Third Quarter 2026 Financial Results
Contrasting TerrAscend (TSNDF) & The Competition
A free stock pick, from me to you
Elon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.tc pixel
TerrAscend to Host Third Quarter 2026 Earnings Conference Call
See More TerrAscend Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TerrAscend? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TerrAscend and other key companies, straight to your email.

About TerrAscend

TerrAscend (OTCMKTS:TSNDF) is a North American cannabis company that cultivates, processes, manufactures and sells cannabis products through a combination of wholesale and retail operations. Its product portfolio includes flower, pre-rolls, concentrates, vape products, edibles, tinctures, topicals and other cannabis-derived products.

The company serves medical and adult-use cannabis markets in several U.S. states, including Pennsylvania, New Jersey, Maryland, Michigan, Ohio and California, as well as the Canadian market. Its retail operations include dispensaries operating under brands such as The Apothecarium, Cookies and Gage, while its wholesale portfolio includes brands such as Kind Tree, Valhalla and Ilera Healthcare.

TerrAscend was established in 2017 and has expanded through acquisitions, new market entries and the development of cultivation and manufacturing facilities. The company focuses on operating within regulated cannabis markets and providing products through its own dispensaries and third-party retail partners.

View TerrAscend Profile